MUCUS RELIEF
- Product NDC
- 68210-0611
- Requested package NDC
- 68210-0611-6
- 11-digit product format
- 682100611
- Labeler code
- 68210
- Product ID
- 68210-0611_ed344b30-f45d-307c-e053-2a95a90a245b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- GUAIFENESIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- SPIRIT PHARMACEUTICALS LLC
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2020-02-11
- Marketing end
- 0000-00-00
- Substance
- GUAIFENESIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68210-0611-6 | MUCUS RELIEF | 60 in 1 BOTTLE | TABLET | 60 | | 6 |
| 68210-0611-6 | MUCUS RELIEF | 1 in 1 CARTON | TABLET | 1 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68210-0611 | MUCUS RELIEF (GUAIFENESIN) TABLET [SPIRIT PHARMACEUTICALS LLC] | 6 | Legacy NDC, 2 package rows | 20241215_0b0ce8a2-7a3a-49cf-8b47-247ddfd93805.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68210-0611-6 | 68210061106 | 1 BOTTLE in 1 CARTON (68210-0611-6) > 60 TABLET in 1 BOTTLE | 1 bottle | 2020-02-11 | 0000-00-00 | No | No | Current |